PCI adds US sterile fill/finish capabilities through $1B global expansion drive
BioSpace
Amid disruption to the outsourced fill/finish market, PCI is investing $100 million to more than double the capacity to fill ready-to-use prefilled syringes and cartridges at its San Diego campus.
pharminent
May 4, 2026 (Last updated: May 4, 2026)
BioSpace
Amid disruption to the outsourced fill/finish market, PCI is investing $100 million to more than double the capacity to fill ready-to-use prefilled syringes and cartridges at its San Diego campus.
